Filing Details
- Accession Number:
- 0001127602-18-011569
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-14 16:40:06
- Reporting Period:
- 2018-03-13
- Accepted Time:
- 2018-03-14 16:40:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1090872 | Agilent Technologies Inc | A | Laboratory Analytical Instruments (3826) | 770518772 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1642192 | Rodney Gonsalves | 5301 Stevens Creek Blvd Santa Clara CA 95051 | V.p., Corporate Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-03-13 | 6,825 | $39.12 | 31,250 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-03-13 | 6,825 | $71.23 | 24,425 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2018-03-13 | 6,825 | $0.00 | 6,825 | $39.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,000 | 2014-11-20 | 2023-11-19 | No | 4 | M | Direct |
Footnotes
- 14.686 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan.
- The weighted average sale price is $71.23 with a range of $71.17 - $71.25.
- Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.
- The option is fully vested and exercisable